Company Encyclopedia
View More
name
Addus Homecare
ADUS.US
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services.
380.95 B
ADUS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care ServicesIndustry
Industry Ranking12/79
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.58%B
    • Profit Margin6.36%B
    • Gross Margin32.21%C
  • Growth ScoreB
    • Revenue YoY18.77%B
    • Net Profit YoY16.30%B
    • Total Assets YoY23.42%A
    • Net Assets YoY10.80%B
  • Cash ScoreB
    • Cash Flow Margin1572.13%B
    • OCF YoY18.77%B
  • Operating ScoreA
    • Turnover1.05A
  • Debt ScoreB
    • Gearing Ratio26.21%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

    Stocks of Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest surged after New York Federal Reserve President John Williams hinted at a potential interest rate cut. The probability of a rate cut in December rose significantly, boosting market sentiment. Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest saw increases of 2.9%, 2.6%, 2.9%, 3%, and 2.8% respectively. Lower interest rates are favorable for growth sectors like healthcare. Addus HomeCare, despite today's rise, is down 8.7% year-to-date and trading below its 52-week high.

    Stock Story·
    US
    ADUS
    -3.16%
    US
    PFE
    +0.51%
    US
    UNH
    -1.83%
    Stock Story·
    US
    ADUS
    -3.16%
    US
    PFE
    +0.51%
    US
    UNH
    -1.83%

    Addus Homecare Executive Sells Millions in Stock!

    Darby Anderson, EVP at Addus Homecare, sold 20,000 shares worth $2.18M. Despite strong Q3 2025 financials, including a 25% revenue increase and strategic acquisitions, challenges like potential Medicaid cuts loom. Analysts remain optimistic, rating ADUS as 'Outperform' due to growth in personal care. However, technical indicators suggest short-term bearishness. YTD price performance is -12.28%, with a market cap of $2.01B.

    Tip Ranks·
    US
    ADUS
    -3.16%
    Tip Ranks·
    US
    ADUS
    -3.16%

    EVP Chief Govt Rel Officer Darby Anderson Reports Disposal of Addus HomeCare Corporation Common Shares

    Darby Anderson, EVP and Chief Govt Rel Officer of Addus HomeCare Corporation, reported the disposal of common shares. The filing is available via EDGAR, Ref. ID: 0001437749-25-035868, dated November 20, 2025. This AI-generated brief is for informational purposes only and not financial advice.

    Reuters·
    US
    ADUS
    -3.16%
    Reuters·
    US
    ADUS
    -3.16%

    Addus HomeCare Corporation $ADUS Stake Lifted by Renaissance Group LLC

    Renaissance Group LLC increased its stake in Addus HomeCare Corporation by 31.3% in Q2, owning 58,197 shares valued at $6.7 million. Other institutional investors also adjusted their holdings. Addus HomeCare reported Q3 earnings of $1.56 per share, surpassing estimates, with revenue up 25% year-over-year. Analysts maintain a "Moderate Buy" rating with a target price of $137.11. Insider trading included EVP Brian Poff selling 7,739 shares.

    Market Beat·
    US
    ADUS
    -3.16%
    Market Beat·
    US
    ADUS
    -3.16%

    Addus HomeCare (ADUS): Assessing Valuation After Recent Share Price Decline

    Addus HomeCare (ADUS) has experienced a 6% stock decline over the past month, continuing a year-to-date downward trend. Despite solid financial growth, the stock is trading below analyst price targets at $109.07. The key question is whether this dip is a buying opportunity. Analyst DanielGC suggests the stock is 29.4% undervalued with a fair value of $154.56, citing strong growth signals and prudent financial management. However, regulatory cuts or wage inflation could impact this outlook.

    Simplywall·
    US
    ADUS
    -3.16%
    Simplywall·
    US
    ADUS
    -3.16%
    © 2025 Longbridge｜Disclaimer